Previous close | 2.4000 |
Open | N/A |
Bid | 0.8500 |
Ask | 2.7500 |
Strike | 7.50 |
Expiry date | 2024-07-19 |
Day's range | 2.4000 - 2.4000 |
Contract range | N/A |
Volume | |
Open interest | 5 |
EMERYVILLE, Calif., May 20, 2024--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating at the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be presenting a corporate overview on Wednesday, June 5th at 8:00 a.m. Eastern time and will be holding one-on-one meetings with investors.
EMERYVILLE, Calif., May 15, 2024--OmniAb, Inc. (Nasdaq: OABI) today announced its participation in the 20th Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the Omni Hotel. Earlier today the Company presented an overview of xPloration, a high-throughput single B-cell screening platform that leverages machine learning and Artificial Intelligence (AI), in a presentation titled "Deep Screening in Harmony with Artificial Intelligence for Bispecific Antibody Discov
OmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call Transcript May 10, 2024 OmniAb, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to OmniAb Inc. First Quarter 2024 Financial Results and Business Update Conference Call. At this […]